In this setting, the vascular normalization in the TME may in fact accelerate tumor growth, as shown previously in GBM and other tumors [20, 54, 55], thereby balancing the negative effect of reduced CCL21-CCR7 signaling in tumor cells. The gene discussed is CCR7; the disease is neoplasm.